Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
GLP-1 receptor agonists, commonly used in managing type 2 diabetes and obesity, have gained attention for their potential implications in colorectal cancer (CRC)
This data illustrates the rapid change: just 23 years prior, virtually no large employers covered GLP-1 weight-loss treatments
Zhu, G., Dudley, D
The side effects that are known include nausea, vomiting, diarrhea, headache, dizziness, compaction in the gastrointestinal tract, and other GI-related symptoms like acid reflux, bloating, etc
US$ 23.24
US$ 29.30
US$ 28.72
